Even without costcuts, the purchase will give a good return on investment. Throw in some synergies, and this looks like an excellent deal. The Belgian chemical and drug group is the latest acquirer in the continuing consolidation of Europe s drug makers.
The conventional wisdom was that banks wouldn t force their way into foreign markets, because to do so would open a can of worms. But the Bank of Italy chief has himself to blame if ABN and BBVA have torn up the rule book. It's Fazio who may have opened a can of worms. The conventional wisdom was that foreign banks wouldn t force their way into Italy, because to do so would open a can of worms.